[Exploration of the mechanisms of portal hypertension driven by metabolic disorders in non-cirrhotic stages of metabolic-associated fatty liver disease]. [PDF]
Zhao YQ, Wang Y, Liu JJ, You H, Zhao JJ.
europepmc +1 more source
[Mechanism of Bushen Yijing Formula improving cognitive function in Alzheimer<b>'</b>s disease model mice]. [PDF]
Zhang Z, Li D, Liu J, Lu L, Cai W, Yu G.
europepmc +1 more source
[Fibroblast growth factor 21 improves alcoholic liver disease by regulating gut microbiota in mice]. [PDF]
Wu GC +5 more
europepmc +1 more source
[Determination of 22 organophosphates and their metabolites and 11 phthalate metabolites in human whole blood by ultra performance liquid chromatography-tandem mass spectrometry]. [PDF]
Shi FY, Xu HY, Li JH, Xu MY.
europepmc +1 more source
[Association between Tau protein deposition and brain metabolites: N-acetylaspartate and creatine as potential biomarkers for advanced Alzheimer's disease]. [PDF]
Li X +7 more
europepmc +1 more source
[Dosage optimization of major components of Yinchenhao decoction for metabolic associated fatty liver disease and its mechanism: an experimental study]. [PDF]
Gao Y +5 more
europepmc +1 more source
[<i>miR</i><b><i>-</i></b><i>16</i><b><i>-</i></b><i>5p</i> alleviates airway inflammation in asthmatic rats by regulating TXNIP and suppressing the NLRP3 signaling axis]. [PDF]
She W +8 more
europepmc +1 more source
[<i>Huoxue Qingjie Ling</i> alleviates bile duct ligation-induced hepatic fibrosis in rats by regulating the Sirt1-autophagy signaling pathway]. [PDF]
Li C +6 more
europepmc +1 more source
[Cajanonic acid A derivative XJ-60 improves liver fibrosis in mice with non-alcoholic fatty liver disease by inhibiting the SP1/TGF-β/Smad3 signaling axis]. [PDF]
Geng Z +8 more
europepmc +1 more source

